Bottom line
BGEAX vs DGEIX: the short answer
BGEAX (Brandes Global Equity Fund) and DGEIX (Global Equity Portfolio) are both mutual funds.
But BGEAX is far broader, holding 69 positions to 6 for DGEIX, so beyond the top names it adds exposure DGEIX doesn't have.
DGEIX is cheaper at 0.25% vs 1.2% — a difference of $95 a year per $10,000 invested.
Over five years, BGEAX returned +14.2% a year vs +11.9% for DGEIX.
BGEAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
BGEAX vs DGEIX side by side
| BGEAX | DGEIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Datum One | Dimensional |
| Category | Global Stock | Global Stock |
| Expense ratio | 1.2% | 0.25% |
| Annual cost per $10k | $120 | $25 |
| 10-yr cost on $10k (prospectus) | $2,093 | $513 |
| Max front load | 5.75% | — |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +25.5% | +20.2% |
| 5-yr return (annualized) | +14.2% | +11.9% |
| 10-yr return (annualized) | +10.0% | +11.9% |
| Best quarter | — | +21.2% |
| Worst quarter | — | −25.9% |
| Net assets (fund) | $82.2M | $11.4B |
| Number of holdings | 69 | 6 |
| Portfolio turnover | 31% | 6% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BGEAX and DGEIX share none of their top holdings.
BGEAX top 10
- Taiwan Semiconductor Manu — 2.88%
- Gsk Plc — 2.58%
- Sap Se — 2.49%
- Becton Dickinson & Co — 2.35%
- Sanofi Sa — 2.32%
- Erste Group Bank Ag — 2.27%
- Cigna Group/the — 2.27%
- Samsung Electronics Co N/ — 2.25%
- Textron Inc — 2.23%
- Ubs Group Ag Usd0.10 (reg — 2.15%
DGEIX top 10
- DFA US Core Equity 2 Portfolio — 53.74%
- DFA US Core Equity 1 Portfolio — 17.94%
- International Core Equity 2 Portfolio — 17.93%
- Emerging Markets Core Equity 2 Portfolio — 8.62%
- DFA Real Estate Securities Portfolio — 1.34%
- DFA International Real Estate Securities — 0.44%
FAQ
What is the difference between BGEAX and DGEIX?
Which is cheaper, BGEAX or DGEIX?
Should I own both BGEAX and DGEIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.